191 related articles for article (PubMed ID: 32140877)
1. Influences on Adherence to Antiretroviral Therapy (ART) in Early-Stage HIV Disease: Qualitative Study from Uganda and South Africa.
Ware NC; Wyatt MA; Pisarski EE; Bwana BM; Orrell C; Asiimwe S; Amanyire G; Musinguzi N; Bangsberg DR; Haberer JE;
AIDS Behav; 2020 Sep; 24(9):2624-2636. PubMed ID: 32140877
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral therapy initiation and adherence in rural South Africa: community health workers' perspectives on barriers and facilitators.
Loeliger KB; Niccolai LM; Mtungwa LN; Moll A; Shenoi SV
AIDS Care; 2016 Aug; 28(8):982-93. PubMed ID: 27043077
[TBL] [Abstract][Full Text] [Related]
3. Differentiated Antiretroviral Therapy Distribution Models: Enablers and Barriers to Universal HIV Treatment in South Africa, Uganda, and Zimbabwe.
Duffy M; Sharer M; Davis N; Eagan S; Haruzivishe C; Katana M; Makina N; Amanyeiwe U
J Assoc Nurses AIDS Care; 2019; 30(5):e132-e143. PubMed ID: 31135515
[TBL] [Abstract][Full Text] [Related]
4. Barriers to HIV Treatment Adherence: A Qualitative Study of Discrepancies Between Perceptions of Patients and Health Providers in Tanzania and Uganda.
Moucheraud C; Stern AF; Ahearn C; Ismail A; Nsubuga-Nyombi T; Ngonyani MM; Mvungi J; Ssensamba J
AIDS Patient Care STDS; 2019 Sep; 33(9):406-413. PubMed ID: 31517526
[TBL] [Abstract][Full Text] [Related]
5. ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa.
Haberer JE; Bwana BM; Orrell C; Asiimwe S; Amanyire G; Musinguzi N; Siedner MJ; Matthews LT; Tsai AC; Katz IT; Bell K; Kembabazi A; Mugisha S; Kibirige V; Cross A; Kelly N; Hedt-Gauthier B; Bangsberg DR
J Int AIDS Soc; 2019 Feb; 22(2):e25232. PubMed ID: 30746898
[TBL] [Abstract][Full Text] [Related]
6. Facilitators and Barriers to Adherence to Antiretroviral Therapy and Retention in Care Among Adolescents Living with HIV/AIDS in Zambia: A Mixed Methods Study.
Mesic A; Halim N; MacLeod W; Haker C; Mwansa M; Biemba G
AIDS Behav; 2019 Sep; 23(9):2618-2628. PubMed ID: 31093820
[TBL] [Abstract][Full Text] [Related]
7. Differentiated Antiretroviral Therapy Delivery: Implementation Barriers and Enablers in South Africa.
Sharer M; Davis N; Makina N; Duffy M; Eagan S
J Assoc Nurses AIDS Care; 2019; 30(5):511-520. PubMed ID: 30720561
[TBL] [Abstract][Full Text] [Related]
8. Social support, disclosure and stigma and the association with non-adherence in the six months after antiretroviral therapy initiation among a cohort of HIV-positive adults in rural KwaZulu-Natal, South Africa
George S; McGrath N
AIDS Care; 2019 Jul; 31(7):875-884. PubMed ID: 30472889
[TBL] [Abstract][Full Text] [Related]
9. "How am I going to live?": exploring barriers to ART adherence among adolescents and young adults living with HIV in Uganda.
MacCarthy S; Saya U; Samba C; Birungi J; Okoboi S; Linnemayr S
BMC Public Health; 2018 Oct; 18(1):1158. PubMed ID: 30286746
[TBL] [Abstract][Full Text] [Related]
10. Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda.
Nabukeera-Barungi N; Elyanu P; Asire B; Katureebe C; Lukabwe I; Namusoke E; Musinguzi J; Atuyambe L; Tumwesigye N
BMC Infect Dis; 2015 Nov; 15():520. PubMed ID: 26573923
[TBL] [Abstract][Full Text] [Related]
11. A qualitative study of patient motivation to adhere to combination antiretroviral therapy in South Africa.
van Loggerenberg F; Gray D; Gengiah S; Kunene P; Gengiah TN; Naidoo K; Grant AD;
AIDS Patient Care STDS; 2015 May; 29(5):299-306. PubMed ID: 25692575
[TBL] [Abstract][Full Text] [Related]
12. What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda.
Bukenya D; Mayanja BN; Nakamanya S; Muhumuza R; Seeley J
AIDS Res Ther; 2019 Jan; 16(1):2. PubMed ID: 30665440
[TBL] [Abstract][Full Text] [Related]
13. What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study.
Mukose AD; Bastiaens H; Makumbi F; Buregyeya E; Naigino R; Musinguzi J; Van Geertruyden JP; Wanyenze RK
PLoS One; 2021; 16(5):e0251181. PubMed ID: 33951109
[TBL] [Abstract][Full Text] [Related]
14. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
[TBL] [Abstract][Full Text] [Related]
15. Determinants of antiretroviral therapy adherence among transgender women in South Africa.
Van der Merwe LL; Moyo I; Mavhandu-Mudzusi AH
S Afr Fam Pract (2004); 2024 Apr; 66(1):e1-e8. PubMed ID: 38708751
[TBL] [Abstract][Full Text] [Related]
16. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.
Davis A; McCrimmon T; Dasgupta A; Gilbert L; Terlikbayeva A; Hunt T; Primbetova S; Wu E; Darisheva M; El-Bassel N
Int J Drug Policy; 2018 Dec; 62():43-50. PubMed ID: 30359872
[TBL] [Abstract][Full Text] [Related]
17. 'I fear my partner will abandon me': the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda.
Alhassan Y; Twimukye A; Malaba T; Myer L; Waitt C; Lamorde M; Colbers A; Reynolds H; Khoo S; Taegtmeyer M
BMC Pregnancy Childbirth; 2022 Jul; 22(1):566. PubMed ID: 35840939
[TBL] [Abstract][Full Text] [Related]
18. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
Holtzman CW; Shea JA; Glanz K; Jacobs LM; Gross R; Hines J; Mounzer K; Samuel R; Metlay JP; Yehia BR
AIDS Care; 2015; 27(7):817-28. PubMed ID: 25671515
[TBL] [Abstract][Full Text] [Related]
19. "Even if you're HIV-positive there's life after if you take your medication": experiences of people on long-term ART in South Africa: a short report.
Hendrickson C; Moolla A; Maskew M; Long L; Fox MP; Sanne I; Majuba P; Pascoe S
AIDS Care; 2019 Aug; 31(8):973-978. PubMed ID: 30913899
[TBL] [Abstract][Full Text] [Related]
20. Treatment adherence in HIV stigmatized environments in South Africa: stigma avoidance and medication management.
Kalichman SC; Mathews C; Banas E; Kalichman MO
Int J STD AIDS; 2019 Mar; 30(4):362-370. PubMed ID: 30501366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
